Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: A phase Ib dose-finding study

S. De Vos^*, L. J. Swinnen, D. Wang, E. Reid, N. Fowler, J. Cordero, M. Dunbar, S. H. Enschede, C. Nolan, A. M. Petrich, J. A. Ross, A. H. Salem, M. Verdugo, S. Agarwal, L. Zhou, M. Kozloff, L. J. Nastoupil, C. R. Flowers

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review